Abstract
INTRODUCTION
Alzheimer’s disease (AD) remains a debilitating condition with limited treatments and additional therapeutic targets needed. Identifying AD protective genetic loci may identify new targets and accelerate identification of therapeutic treatments. We examined a founder population to identify loci associated with cognitive preservation into advanced age.
METHODS
Genome-wide association and linkage analyses were performed on 946 examined and sampled Amish individuals, aged 76–95, who were either cognitively unimpaired (CU) or impaired (CI).
RESULTS
A total of 12 single nucleotide polymorphisms (SNPs) demonstrated suggestive association (P ≤ 5 × 10−4) with cognitive preservation. Genetic linkage analyses identified > 100 significant (logarithm of the odds [LOD] ≥ 3.3) SNPs, some which overlapped with the association results. Only one locus on chromosome 2 retained significance across multiple analyses.
DISCUSSION
A novel significant result for cognitive preservation on chromosome 2 includes the genes LRRTM4 and CTNNA2. Additionally, the lead SNP, rs1402906, impacts the POU3F2 transcription factor binding affinity, which regulates LRRTM4 and CTNNA2.
Highlights
GWAS and linkage identified over 100 loci associated with cognitive preservation.
One locus on Chromosome 2 retained significance over multiple analyses.
Predicted TFBSs near rs1402906 regulate genes associated with neurocognition.
If you do not see content above, kindly GO TO SOURCE.
Not all publishers encode content in a way that enables republishing at Neuro.vip.
This post is Copyright: Leighanne R. Main,
Yeunjoo E. Song,
Audrey Lynn,
Renee A. Laux,
Kristy L. Miskimen,
Michael D. Osterman,
Michael L. Cuccaro,
Paula K. Ogrocki,
Alan J. Lerner,
Jeffery M. Vance,
Denise Fuzzell,
Sarada L. Fuzzell,
Sherri D. Hochstetler,
Daniel A. Dorfsman,
Laura J. Caywood,
Michael B. Prough,
Larry D. Adams,
Jason E. Clouse,
Sharlene D. Herington,
William K. Scott,
Margaret A. Pericak‐Vance,
Jonathan L. Haines | October 8, 2024